Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Research

The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999–2018

Authors: Fatemeh Koohi, Karim Kohansal, Marzieh Saei Ghare Naz, Somayeh Derakhshan, Fereidoun Azizi, Davood Khalili

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

Assessing the risk of cardiovascular disease (CVD) is crucial in preventive cardiology. We aimed to determine the trend of CVD risk among individuals with and without diabetes during two decades of follow-up in a Middle Eastern cohort.

Methods

We studied 8,450 individuals (55.5% women) aged 40–75 years who participated in the Tehran Lipid and Glucose Study (TLGS). Diabetes status and CVD risk factors were evaluated in six examinations from 1999 to 2018. The individual 10-year CVD risk score was calculated using the ACC/AHA recommended risk equation. We used generalized estimating equation models (GEE) to assess the time trends of CVD risk factors and CVD risk scores in diabetic and non-diabetic groups separately.

Results

The age-adjusted ACC/AHA risk score significantly decreased in non-diabetic women and men (from 3.2% to 1.6% in women and 6.8% to 5.0% in men; p for trend < 0.001). Whereas the risk significantly decreased among diabetics men (from 13.8% to 11.5%), it increased somehow among diabetics women (from 5.3% to 5.5%). Furthermore, in both sexes, diabetic individuals compared to non-diabetic ones had better control on their systolic blood pressure, total cholesterol, and fasting plasma glucose during the last two decades.

Conclusions

The CVD risk and most CVD risk factors improved in individuals with and without diabetes in the past two decades; however, they have not reached the targets yet. So, more stringent lifestyle modifications and treatment strategies are needed, especially for primary prevention in the general population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Setia S, Fung SS-W, Waters DD. Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore. Vasc Health Risk Manag. 2015;11:303.CrossRef Setia S, Fung SS-W, Waters DD. Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore. Vasc Health Risk Manag. 2015;11:303.CrossRef
2.
go back to reference Oguoma VM, Nwose EU, Skinner TC, Digban KA, Onyia IC, Richards RS. Prevalence of cardiovascular disease risk factors among a Nigerian adult population: relationship with income level and accessibility to CVD risks screening. BMC Public Health. 2015;15(1):397.CrossRef Oguoma VM, Nwose EU, Skinner TC, Digban KA, Onyia IC, Richards RS. Prevalence of cardiovascular disease risk factors among a Nigerian adult population: relationship with income level and accessibility to CVD risks screening. BMC Public Health. 2015;15(1):397.CrossRef
3.
go back to reference Willis A, Rivers P, Gray LJ, Davies M, Khunti K. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PloS One. 2014;9(4):e91157.CrossRef Willis A, Rivers P, Gray LJ, Davies M, Khunti K. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PloS One. 2014;9(4):e91157.CrossRef
5.
go back to reference Saadat S, Yousefifard M, Asady H, Jafari AM, Fayaz M, Hosseini M. The most important causes of death in Iranian population; a retrospective cohort study. Emergency. 2015;3(1):16.PubMedPubMedCentral Saadat S, Yousefifard M, Asady H, Jafari AM, Fayaz M, Hosseini M. The most important causes of death in Iranian population; a retrospective cohort study. Emergency. 2015;3(1):16.PubMedPubMedCentral
7.
go back to reference Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M. Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: the impact of demographic changes. Iran J Public Health. 2017;46(4):506.PubMedPubMedCentral Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M. Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: the impact of demographic changes. Iran J Public Health. 2017;46(4):506.PubMedPubMedCentral
8.
go back to reference Sarrafzadegan N, Kelishadi R, Esmaillzadeh A, Mohammadifard N, Rabiei K, Roohafza H, et al. Do lifestyle interventions work in developing countries? findings from the isfahan healthy heart program in the Islamic Republic of Iran. Bull World Health Organ. 2009;87:39–50.CrossRef Sarrafzadegan N, Kelishadi R, Esmaillzadeh A, Mohammadifard N, Rabiei K, Roohafza H, et al. Do lifestyle interventions work in developing countries? findings from the isfahan healthy heart program in the Islamic Republic of Iran. Bull World Health Organ. 2009;87:39–50.CrossRef
9.
go back to reference Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, et al. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a middle eastern cohort study. PloS One. 2014;9(12):e112639.CrossRef Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, et al. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a middle eastern cohort study. PloS One. 2014;9(12):e112639.CrossRef
10.
go back to reference Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol. 2005;34(2):413–21.CrossRef Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol. 2005;34(2):413–21.CrossRef
11.
go back to reference Poulter N. Benefits and pitfalls of cardiovascular risk assessment. J Hum Hypertens. 2000;14(2):S11–6.CrossRef Poulter N. Benefits and pitfalls of cardiovascular risk assessment. J Hum Hypertens. 2000;14(2):S11–6.CrossRef
12.
go back to reference Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/american heart association task force on practice guidelines. J Ame Coll Cardiol. 2014;63(25 Part B):2935–59.CrossRef Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/american heart association task force on practice guidelines. J Ame Coll Cardiol. 2014;63(25 Part B):2935–59.CrossRef
13.
go back to reference Azizi F, Madjid M, Rahmani M, Emami H, Mirmiran P, Hadjipour R. Tehran Lipid and Glucose Study (TLGS): rationale and design. 2000. Azizi F, Madjid M, Rahmani M, Emami H, Mirmiran P, Hadjipour R. Tehran Lipid and Glucose Study (TLGS): rationale and design. 2000.
14.
go back to reference Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):5.CrossRef Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):5.CrossRef
15.
go back to reference Karam C, Beauchet A, Czernichow S, de Roquefeuil F, Bourez A, Mansencal N, et al. Trends in cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in a large untreated French urban population: the CARVAR 92 Study. PLoS One. 2015;10(4):e0124817.CrossRef Karam C, Beauchet A, Czernichow S, de Roquefeuil F, Bourez A, Mansencal N, et al. Trends in cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in a large untreated French urban population: the CARVAR 92 Study. PLoS One. 2015;10(4):e0124817.CrossRef
16.
go back to reference Zhou L, Zhao X, Heizhati M, Abulikemu S, Zhang D, Cheng Q, Ouyang W, Yao X, Hong J, Wu T, Xiamili Z, Li N. Trends in lipids and lipoproteins among adults in Northwestern Xinjiang, China, from 1998 through 2015. J Epidemiol. 2019;29(7):257–63. https://doi.org/10.2188/jea.JE20180018. Zhou L, Zhao X, Heizhati M, Abulikemu S, Zhang D, Cheng Q, Ouyang W, Yao X, Hong J, Wu T, Xiamili Z, Li N. Trends in lipids and lipoproteins among adults in Northwestern Xinjiang, China, from 1998 through 2015. J Epidemiol. 2019;29(7):257–63. https://​doi.​org/​10.​2188/​jea.​JE20180018.
17.
go back to reference Ford ES. Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among US adults from 1999 to 2010. J Am Coll Cardiol. 2013;61(22):2249–52.CrossRef Ford ES. Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among US adults from 1999 to 2010. J Am Coll Cardiol. 2013;61(22):2249–52.CrossRef
18.
go back to reference Malekzadeh H, Lotfaliany M, Ostovar A, Hadaegh F, Azizi F, Yoosefi M, et al. Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007–2016. Sci Rep. 2020;10(1):1–10.CrossRef Malekzadeh H, Lotfaliany M, Ostovar A, Hadaegh F, Azizi F, Yoosefi M, et al. Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007–2016. Sci Rep. 2020;10(1):1–10.CrossRef
19.
go back to reference Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran lipid and glucose study. PloS One. 2014;9(7):e102563.CrossRef Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran lipid and glucose study. PloS One. 2014;9(7):e102563.CrossRef
20.
go back to reference Sasso FC, Pafundi PC, Simeon V, De Nicola L, Chiodini P, Galiero R, et al. Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease. Cardiovasc Diabetol. 2021;20(1):145.CrossRef Sasso FC, Pafundi PC, Simeon V, De Nicola L, Chiodini P, Galiero R, et al. Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease. Cardiovasc Diabetol. 2021;20(1):145.CrossRef
21.
go back to reference Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95–9.CrossRef Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95–9.CrossRef
22.
go back to reference Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Khajeh E, et al. Awareness, treatment and control of pre-hypertension and hypertension among adults in Iran. 2016. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Khajeh E, et al. Awareness, treatment and control of pre-hypertension and hypertension among adults in Iran. 2016.
23.
go back to reference Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran University Heart Center. 2016;11(4):159. Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran University Heart Center. 2016;11(4):159.
24.
go back to reference Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017–2018. 2020. Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017–2018. 2020.
25.
go back to reference Zhu Z, Bundy JD, Mills KT, Bazzano LA, Kelly TN, Zhang Y, et al. Secular trends in cardiovascular health in US Adults (from NHANES 2007 to 2018). Am J Cardiol. 2021;159:121–8.CrossRef Zhu Z, Bundy JD, Mills KT, Bazzano LA, Kelly TN, Zhang Y, et al. Secular trends in cardiovascular health in US Adults (from NHANES 2007 to 2018). Am J Cardiol. 2021;159:121–8.CrossRef
26.
go back to reference Kheirandish M, Asgari S, Lotfaliany M, Bozorgmanesh M, Saadat N, Tohidi M, et al. Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis. 2014;13(1):1–13.CrossRef Kheirandish M, Asgari S, Lotfaliany M, Bozorgmanesh M, Saadat N, Tohidi M, et al. Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis. 2014;13(1):1–13.CrossRef
27.
go back to reference Baghbani-Oskouei A, Tohidi M, Asgari S, Ramezankhani A, Azizi F, Hadaegh F. Serum Lipids during 20 years in the Tehran Lipid and glucose study: prevalence, trends and impact on non-communicable diseases. Int J of Endocrinol Metab. 2018;16(4 Suppl):e84750. Baghbani-Oskouei A, Tohidi M, Asgari S, Ramezankhani A, Azizi F, Hadaegh F. Serum Lipids during 20 years in the Tehran Lipid and glucose study: prevalence, trends and impact on non-communicable diseases. Int J of Endocrinol Metab. 2018;16(4 Suppl):e84750.
28.
go back to reference Sun X, Du T. Trends in cardiovascular risk factors among US men and women with and without diabetes, 1988–2014. BMC Public Health. 2017;17(1):1–13.CrossRef Sun X, Du T. Trends in cardiovascular risk factors among US men and women with and without diabetes, 1988–2014. BMC Public Health. 2017;17(1):1–13.CrossRef
29.
go back to reference Kwon Y-J, Lee J-W, Kang H-T. Secular trends in lipid profiles in Korean adults based on the 2005–2015 KNHANES. Int J Environ Res Public Health. 2019;16(14):2555.CrossRef Kwon Y-J, Lee J-W, Kang H-T. Secular trends in lipid profiles in Korean adults based on the 2005–2015 KNHANES. Int J Environ Res Public Health. 2019;16(14):2555.CrossRef
30.
go back to reference Mohammadifard N, Toghianifar N, Sajjadi F, Alikhasi H, Kelishadi R, Maghroun M, et al. Improvement of dietary oil consumption following a community trial in a developing country: the role of translational research in health promotion. ARYA atherosclerosis. 2013;9(1):29.PubMedPubMedCentral Mohammadifard N, Toghianifar N, Sajjadi F, Alikhasi H, Kelishadi R, Maghroun M, et al. Improvement of dietary oil consumption following a community trial in a developing country: the role of translational research in health promotion. ARYA atherosclerosis. 2013;9(1):29.PubMedPubMedCentral
31.
go back to reference Torabi P, Zare F, Shekholeslam R, Safavi S, editors. Study of vegetable oil consumption in 15 pilot universities of Iran. Iran: 12th Nutritional Congress Tabriz; 2004. Torabi P, Zare F, Shekholeslam R, Safavi S, editors. Study of vegetable oil consumption in 15 pilot universities of Iran. Iran: 12th Nutritional Congress Tabriz; 2004.
32.
go back to reference Palmer MK, Toth PP. Trends in lipids obesity metabolic syndrome and diabetes mellitus in the United States: An NHANES analysis (2003‐2004 to 2013‐2014). Obesity. 2019;27(2):309–14.CrossRef Palmer MK, Toth PP. Trends in lipids obesity metabolic syndrome and diabetes mellitus in the United States: An NHANES analysis (2003‐2004 to 2013‐2014). Obesity. 2019;27(2):309–14.CrossRef
33.
go back to reference Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2· 7 million participants. The lancet. 2011;378(9785):31–40.CrossRef Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2· 7 million participants. The lancet. 2011;378(9785):31–40.CrossRef
34.
go back to reference Fang M. Trends in diabetes management among US adults: 1999–2016. J Gen Intern Med. 2020;35(5):1427–34.CrossRef Fang M. Trends in diabetes management among US adults: 1999–2016. J Gen Intern Med. 2020;35(5):1427–34.CrossRef
35.
go back to reference Meysamie A, Ghalehtaki R, Ghodsi S, Esteghamati A, Mohammad K, Etemad K, et al. Trend of cigarette smoking in Iranian adult population from 2000 to 2011 based on four national surveys. Social Determinants of Health. 2017;3(3):148–59. Meysamie A, Ghalehtaki R, Ghodsi S, Esteghamati A, Mohammad K, Etemad K, et al. Trend of cigarette smoking in Iranian adult population from 2000 to 2011 based on four national surveys. Social Determinants of Health. 2017;3(3):148–59.
36.
go back to reference Nemati S, Rafei A, Freedman ND, Fotouhi A, Asgary F, Zendehdel K. Cigarette and water-pipe use in Iran: geographical distribution and time trends among the adult population; a pooled analysis of national STEPS surveys, 2006–2009. Arch Iran Med. 2017;20(5):295–301.PubMed Nemati S, Rafei A, Freedman ND, Fotouhi A, Asgary F, Zendehdel K. Cigarette and water-pipe use in Iran: geographical distribution and time trends among the adult population; a pooled analysis of national STEPS surveys, 2006–2009. Arch Iran Med. 2017;20(5):295–301.PubMed
37.
go back to reference Organization WH. WHO global report on trends in prevalence of tobacco use 2000–2025: World Health Organization. 2019. Organization WH. WHO global report on trends in prevalence of tobacco use 2000–2025: World Health Organization. 2019.
38.
go back to reference Alimohammadi M, Jafari-Mansoorian H, Hashemi SY, Momenabadi V, Ghasemi SM, Karimyan K. Review on the implementation of the Islamic Republic of Iran about tobacco control, based on MPOWER, in the framework convention on tobacco control by the World Health Organization. Addict Health. 2017;9(3):183.PubMedPubMedCentral Alimohammadi M, Jafari-Mansoorian H, Hashemi SY, Momenabadi V, Ghasemi SM, Karimyan K. Review on the implementation of the Islamic Republic of Iran about tobacco control, based on MPOWER, in the framework convention on tobacco control by the World Health Organization. Addict Health. 2017;9(3):183.PubMedPubMedCentral
Metadata
Title
The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999–2018
Authors
Fatemeh Koohi
Karim Kohansal
Marzieh Saei Ghare Naz
Somayeh Derakhshan
Fereidoun Azizi
Davood Khalili
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-12981-9

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue